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Abstract
Many neurodegenerative diseases share a common pathological feature: the deposition of amyloid-like fibrils composed of
misfolded proteins. Emerging evidence suggests that these proteins may spread from cell-to-cell and encourage the
propagation of neurodegeneration in a prion-like manner. Here, we demonstrated that a-synuclein (aSYN), a principal
culprit for Lewy pathology in Parkinson’s disease (PD), was present in endosomal compartments and detectably secreted
into the extracellular milieu. Unlike prion protein, extracellular aSYN was mainly recovered in the supernatant fraction rather
than in exosome-containing pellets from the neuronal culture medium and cerebrospinal fluid. Surprisingly, impaired
biogenesis of multivesicular body (MVB), an organelle from which exosomes are derived, by dominant-negative mutant
vacuolar protein sorting 4 (VPS4) not only interfered with lysosomal targeting of aSYN but facilitated aSYN secretion. The
hypersecretion of aSYN in VPS4-defective cells was efficiently restored by the functional disruption of recycling endosome
regulator Rab11a. Furthermore, both brainstem and cortical Lewy bodies in PD were found to be immunoreactive for VPS4.
Thus, VPS4, a master regulator of MVB sorting, may serve as a determinant of lysosomal targeting or extracellular secretion
of aSYN and thereby contribute to the intercellular propagation of Lewy pathology in PD.
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Introduction
Although the pathophysiology of Parkinson’s disease (PD) is still
a topic of debate, the current consensus is that the cytoplasmic
accumulation of fibrillar a-synuclein (aSYN) in the affected brain
lesions is a hallmark of the initiation and progression of the disease
[1,2,3,4,5]. In human brain, aSYN is enriched in presynaptic
nerve terminals and is mainly detected both in cytosolic and
synaptosomal fractions [6,7]. On the other hand, both monomeric
and oligomeric aSYN has been found in the neuronal culture
medium as well as in body fluids such as plasma and cerebrospinal
fluid (CSF) [8,9,10,11]. The existence of extracellular aSYN is also
supported by the fact that the hydrophobic core region of aSYN,
termed NAC (non-amyloid-b component), is observed in the
extracellular senile plaques of Alzheimer’s disease (AD) [12]. The
biochemical influence of extracellular aSYN is not understood yet,
but in vitro generated soluble aSYN oligomers can induce
transmembrane seeding of aSYN aggregation and eventually
cause neuronal cell death [13]. The intercellular transmission of
aSYN is also verified by co-culture experiments and in vivo animal
models showing that aSYN aggregates released from neuronal
cells can be transferred to neighboring cells and form intracellular
inclusions [14,15,16,17]. Moreover, it has been shown that aSYN-
containing conditioned medium not only induced neuronal death,
but also triggered inflammatory responses in astroglial cells [15].
Finally, the in vivo cell-to-cell propagation of pathogenic protein
was strongly supported by recent observations showing that
aSYN-positive, Lewy body-like cytoplasmic inclusions were found
in fetal mesencephalic neurons that were transplanted into the
brain of PD patients more than a decade ago [18,19,20]. This
scenario is immensely attractive as an acceptable explanation for
the clinically observed progression of neurodegenerative diseases
as well as the stereotypic spread of Lewy pathology suggested by
Braak and his colleagues [21].
The cellular and molecular mechanisms by which intercellular
transmission of infectious prions occurs are still enigmatic.
Nevertheless, several reports revealed that both normal cellular
prion protein (PrPc) and the abnormally folded pathogenic form
(PrPsc) were associated with nanovesicles called ‘exosomes’
released from non-neuronal and neuronal cells [22,23,24,25].
Once released from a cell it is proposed that exosomes could fuse
with the plasma membrane of neighboring cells, transferring
exosomal molecules from one cell to another. Vesicles with the
hallmarks of exosomes have been detected in a large variety of
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[26]. Very recently, it was shown that part of the cell-produced
aSYN can be secreted via an exosomal, calcium-dependent
mechanism and that the exosome-containing conditioned medium
from aSYN-expressing cells caused the cell death of recipient
neuronal cells [27]. Another piece of evidence showed that
lysosomal dysfunction led to an increase in the release of aSYN in
exosomes and a concomitant increase in aSYN transmission to
recipient cells [28]. These findings raise the possibility that
methods to prevent pathogenic protein trafficking and propagation
could be designed from insights concerning the mechanisms
involved in exosome biogenesis.
Multivesicular bodies (MVBs), the endocytic organelles from
which exosomes are derived, are generated from the invagination
of the limiting membrane into the luminal space [29,30,31].
MVBs are involved in the sequestration of proteins that are
condemned to lysosomal degradation. An alternative destination
of MVBs is their exocytic fusion with the plasma membrane
leading to the release of intraluminal vesicles (ILVs; i.e., exosome)
into the extracellular environment. Mechanistically, the sorting of
cargo proteins into ILVs from MVBs is a tightly regulated process
that depends on a functional complex called ESCRT (Endosomal
Sorting Complex Required for Transport) [32,33,34]. This highly
conserved machinery consists of three distinct but cooperative
functions: first, it recognizes ubiquitylated cargo protein; second, it
promotes membrane deformation, facilitating the cargo to be
sorted into endosomal invaginations; third, it catalyzes the final
perimeter membrane scission of the endosomal invagination,
which forms ILVs containing the sorted cargo [35]. During these
processes, AAA (ATPases Associated with diverse cellular
Activities)-ATPase VPS4 (Vacuolar Protein Sorting 4) is required
for the final ESCRT-disassembly, which completes the membrane
abscission and is thus indispensable for MVB biogenesis [36].
Functional VPS4 is composed of two parallel hexameric rings
made of VPS4A and B. It is known that VPS4 paralogues are
differentially expressed in different organs, e.g., the expression of
VPS4A is higher than that of VPS4B in mouse brain. [37].
We now report that, in contrast to PrP, extracellular aSYN was
mainly detected in the supernatant fraction rather than in
exosome-containing pellets from neuronal culture medium (CM)
and CSF. Furthermore, perturbation of MVB-exosome genesis by
dominant negative (DN) VPS4A unexpectedly increased extracel-
lular aSYN concomitant with decreased lysosomal targeting of
aSYN. The aberrant secretion of aSYN induced by VPS4
malfunction was effectively restored by the functional disruption
of recycling endosome regulator Rab11a. Our results uncover a
novel functional role of the MVB sorting pathway in the
extracellular secretion as well as lysosomal targeting of aSYN.
Results
a-Synuclein Is Present in Endosomal Compartments
In eukaryotic cells, endosomes comprise three different
compartments: early endosomes, late endosomes, and recycling
endosomes. They are not only distinguished by morphology,
differential density, and internal pH, but also by the specific
localization of Rab GTPases [38,39]. To determine whether
aSYN is actually localized in the endosomal compartment in
cultured cells, we transiently transfected Myc-aSYN-expressing
HEK293T and human neuronal SH-SY5Y cells together with
EGFP-tagged Rab GTPase Rab5a, Rab7, and Rab11a, which are
indispensable effectors/constituents of early endosomes, late
endosomes, and recycling endosomes, respectively [39]. The
reason why we used HEK293T cells is that they are very easy to
transfect and the level of protein expression is very high. As shown
in Fig. 1A and B, exogenously expressed aSYN in both cells was
clearly detected not only throughout the cytosol but also in
punctate endosomal structures, which were positive for EGFP-
Rab5a, Rab7, and Rab11a. The partial co-localization of
endogenous aSYN with endosomal Rab proteins was also
observed in human neuronal SH-SY5Y cells (Fig. 1C). The
patterns of distribution of EGFP-tagged Rab family proteins were
quite distinct from those of the EGFP-expressing cells, showing
diffuse cytoplasmic signals throughout the cytosol (data not
shown).
a-Synuclein Is Detected in Supernatant But Not in
Exosome-Containing Pellet from Neuronal Culture
Medium and CSF
To investigate whether aSYN is released in association with
exosomes into the extracellular milieu, we induced wt and A53T
mutant aSYN expression in SH-SY5Y cells and examined the CM
as well as whole cell lysates for the presence of aSYN (Fig. 2A).
The collected medium was further separated into the supernatant
and an exosome-containing pellet, and the successful separation
was verified using the exosome marker Alix. After induction,
aSYN monomer and high molecular weight (HMW) aSYN smear
were significantly increased in the cell lysates. A53T mutant aSYN
had a high propensity to form HMW smear, as previously
reported [2,40]. Following the induction, wt and, to a lesser extent
A53T mutant aSYN, in the supernatant of CM were easily
detected and dramatically increased. However, the expression
levels of aSYN in the exosome-containing pellet were very weak
and unchanged even after the induction. Thus, it is supposed that
the majority of secreted aSYN in CM is not concealed in exosome
vesicles, but released directly into the supernatant. We confirmed
that the presence of aSYN in CM was not attributable to
disruption of the cellular membrane since Hsp90, the most
abundantly expressed protein in the cytosol of eukaryotic cells,
could not be detected in the samples prepared from CM. To
confirm the extracellularaSYN localization in more detail, the
resuspended exosome-containing 100,0006g pellets obtained from
CM were further analyzed by floatation in a continuous sucrose-
density gradient (Fig. 2B). As expected, Western blot analysis of
the separated fractions revealed that PrP migrated near the top of
the density gradient with concomitant enrichment of the exosome-
associated proteins, Alix and Flottilin-1. By contrast, only trace
amounts of aSYN were broadly detected in the sucrose gradient
and no exosomal enrichment was observed. The separation
appeared to be successful since exosomes have been reported to
float on sucrose gradients at density ranges depending on the cell
type [41].
PrP can be detected in several biological fluids such as blood,
lymph, and CSF, which are confirmed to be sources of prion
infectivity [42]. Furthermore, exosomes isolated from ovine CSF
were an efficient means of enriching PrPc and PrPsc suitable for
detection using Western blot analysis [41]. While detectable
amounts of aSYN have also been identified in human blood
plasma and CSF [8,9,10,11], it has not yet been determined
whether aSYN is enriched in exosomes derived from CSF. In an
attempt to examine whether CSF-derived exosomes were enriched
in aSYN relative to neat CSF, we pooled CSF samples from five
different PD patients together with age-matched controls and then
the exosomes were isolated by ultracentrifugation. Equal concen-
trations (50 mg per lane) of total CSF samples were loaded
alongside CSF-derived exosomes and then probed with anti-aSYN
and PrP antibodies (Fig. 2C). The amount of PrP detected in CSF-
derived exosomes was enriched compared to neat CSF in which
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weakly but specifically detected in neat CSF; however, we failed to
detect aSYN-positive signals in CSF-derived exosomes by
standard immunoblotting technique. There was no significant
difference in the expression levels of CSF aSYN between PD
patients and normal controls.
Expression of DN VPS4A Leads to Increased Extracellular
a-Synuclein and a Parallel Decrease in Lysosomes
Exosomes, by definition, correspond to the ILV of MVB, and
therefore targeting a component of the ESCRT machinery could
be used to interrupt protein sorting to ILV and exosome formation
[22,30]. In fact, it has been shown that disturbed ILV formation
by the over-expression of DN-VPS4A induced PrPc entrapment at
the limiting membrane of endosomes in rabbit epithelial Rov9
cells [43]. Thus, we hypothesized that, if aSYN secretion largely
depends on exosomes as well as PrPc, functional disruption of the
ESCRT components by DN-VPS4A could decrease extracellular
aSYN. To prove this, aSYN-expressing HEK293T cells were co-
transfected either with 3XFLAG-tagged wt-VPS4A or DN mutant
(E228Q) VPS4A harbouring a single amino acid exchange in its
AAA domain [44]. Forty-eight hours post-transfection, the cells
were harvested and sequentially fractionated into cytosolic,
endosomal, and lysosomal fractions. In parallel, proteins in
cultured medium were isolated by TCA/acetone precipitation.
All samples were subjected to immunoblot analysis and the relative
purity of the fractions was assessed using antibodies against specific
markers including LAMP-1 (lysosome), Rab5 (early endosome),
Rab11 (recycling endosome), Hsp90 (cytosol), and BSA (CM),
respectively. The results, shown in Fig. 3A, revealed that
exogenous expression of DN-VPS4A, and a lesser extent wt-
VPS4A, caused an unexpected increase of both monomeric and
oligomeric aSYN in CM compared to mock (3XFLAG peptide)-
transfected control. The partial increase of aSYN secretion by wt-
VPS4A expression could be explained by previous data demon-
strating that even wt-VPS4A was able to negatively perturb the
ESCRT pathway when heavily over-expressed [45]. An intriguing
finding was that the increased aSYN secretion into CM was
accompanied by a slight decrease of lysosomal HMW aSYN
smear (i.e., oligomers), since the autophagic-lysosomal pathway
had been thought to be essential for the clearance of aSYN
aggregates [46,47,48]. In accord with these findings, we confirmed
that bafilomycin A1, a cell-permeant inhibitor of vacuolar type
H+-ATPase, which plays a pivotal role in acidification and protein
degradation in lysosomes, induced the buildup of cellular aSYN
oligomers in parallel with the increase of its extracellular secretion
in a dose-dependent manner (Fig. 3B). It is also interesting to note
that the accumulated aSYN oligomers in HEK293T cells were
prominent in CM, endosomal, and lysosomal compartments
compared to those in the cytosol, which is in good agreement
with a previous study showing that aSYN is more prone to
aggregate in vesicular structures compared to the cysotol [49].
Also note that endosomal proteins including aSYN seemed to be
heavily ubiquitylated compared to aSYN in other fractions. As
previously reported, immunostaining revealed that exogenous
expression of DN-VPS4A in HEK293T cells led to the appearance
Figure 1. a-synuclein is present in endosomal compartments.
Colocalization experiments of Myc-tagged aSYN (red) with endosome-
associated EGFP-tagged Rab proteins (green) in HEK293T cell (A) and
SH-SY5Y dopaminergic neuronal cells (B). The subcellular distribution of
endogenous aSYN was also examined in SH-SY5Y cells expressing EGFP-
tagged Rab proteins (C). Cells were fixed 48 hours post-transfection and
were subjected to immunofluorescent analysis. In both cell lines,
exogenously expressed aSYN was detected not only throughout the
cytosol but also in punctate endosomal structures that were positive for
EGFP-Rab5a (early endosome marker), Rab7 (late endosome marker),
and Rab11a (recycling endosome marker), respectively. Nuclei were
conterstained with TO-PRO3 iodide (pseudocolored blue). The inset
picture is a magnified picture of the square area. Immunostaining was
performed three times and the experiment three times with the same
results. Size bar: 10 mm.
doi:10.1371/journal.pone.0029460.g001
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by standard immunoblot analysis. A. wt and A53T mutant aSYN were inducibly expressed in SH-SY5Y cells for 48 hours. Culture medium as well
as whole cell lysates (50 mg protein per lane) were subjected to Western blot analysis. The collected media were further separated into the
supernatant and exosome-containing pellets before loading onto gels. Alix, Hsp90, and BSA were used as markers for exosome, cytosol, and culture
medium, respectively. In the neuronal culture medium, both monomeric/oligomeric wt and mutant aSYN were recovered in the supernatant (dagger)
rather than exosome-containing pellets (hash). Asterisk indicates unspecific band. B. The resuspended exosome-containing pellets from the culture
medium were further separated by sucrose-density gradient followed by Western blot analysis. Immunoblot probed with synuclein-1 anti-aSYN, anti-
PrP Abs and the successful separation of exosome was confirmed by exosomal markers, Flotillin-1 and Alix. As shown in the blot, PrP migrated near
the top of the density gradient (fraction #8) with concomitant enrichment of exosome-associated proteins. By contrast, no exosomal enrichment was
observed with aSYN. C. CSF (1.5 mL) from 5 PD patients together with age-matched controls was pooled and exosome-containing pellets were
isolated by successive centrifugation indicated. Equal concentrations (50 mg per lane) of total CSF samples were loaded alongside CSF-derived
exosomes and then probed with anti-aSYN and PrP antibodies. PrP detected in CSF-derived exosomes was enriched compared to neat CSF. aSYN was
weakly but specifically detected in neat CSF, whereas no aSYN-positive signal could be detected in CSF-derived exosomes. No significant difference
was observed in the expression levels of CSF aSYN between PD patients and normal controls. Representative Western blots from three independent
experiments are presented.
doi:10.1371/journal.pone.0029460.g002
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contrast to the diffuse perinuclear distribution of wt-VPS4A
(Fig. 3C) [43]. We confirmed that the aberrant secretion of aSYN
by DN-VPS4A expression was not a cell-type-specific phenome-
non in HEK293T cells since we observed an identical result in
SH-SY5Y neuronal cells, namely, wt as well as A53T mutant
aSYN secretion was significantly increased by the nucleofection of
wt- and DN-VPS4A (Fig. 4A). Note that the extracellular secretion
of monomeric wt-aSYN was much higher than that of A53T
mutant aSYN in mock-transfected cells as well as in DN-VPS4A
engineered cells (Fig. 4B). Nucleofection of SH-SY5Y cells using
the Nucleofector device provided a technique for introducing
constructs into SH-SY5Y cells with ,70% efficiency as estimated
from the EGFP fluorescence at 48 hours post-transfection (our
unpublished data).
VPS4 is found in the core structures of Lewy bodies
As shown in Fig. 3A, we found that aSYN in endosome and
lysosome is more prone to aggregate than in cytosol. This result
implies that endosomal/lyosomal organelles containing aSYN
aggregates might be the potential source of Lewy bodies. To prove
this, the substantia nigra and the temporal lobes from four patients
with PD and four age-matched controls dying from known, non-
neurological causes were subjected to immunohistochemical
analysis using anti-human VPS4 Ab. In all brain tissues from
PD patients, the core structures of Lewy bodies showed VPS4
immunoreactivity (Fig. 5), whereas only weak background staining
was observed in control brain sections (data not shown). The
percentage of VPS4-immunoreactive Lewy bodies in the substan-
tia nigra (A and B) and the temporal lobes (C and D) of four PD
brains are 90% and 10%, respectively.
Increased Secretion of a-Synuclein by DN-VPS4A Is
Restored by DN-Rab11a
It was shown that aSYN incorporated from the extracellular
space was able to be resecreted out of neurons via a process
modulated by recycling endosome regulator Rab11a [50]. To test
the possible implication of the Rab11a-dependent recycling
pathway in the secretion of aSYN in vivo, aSYN-expressing
HEK293T cells were co-transfected with EGFP, EGFP-tagged wt-
Rab11a, Q70L constitutively active (CA)-Rab11a, or S25N DN-
Rab11a construct, respectively (Fig. 6). The S25N point mutation
in Rab11a has been known to increase its activity for GDP,
thereby locking the Rab GTPase in an inactive, non-membrane-
associated state [51]. In comparison with EGFP, wt-Rab11a, and
CA-Rab11a expressing cells, the cells expressing DN-Rab11a
showed a slight decrease of the extracellular oligomeric aSYN in
CM as well as the appearance of aSYN-immunopositive HMW
smear in the endosome and, to a lesser extent, cytosolic and
lysosomal fractions. This finding indicated that a part of
endogenous aSYN was trafficked via a recycling endosome
pathway for extracellular secretion, and the reduced recycling
efficiency by DN-Rab11a expression would probably yield the
aberrant retention of aSYN both in endosomes and lysosomes.
Given the role of Rab11a in regulating the secretion of cellular
aSYN, we speculated that the Rab11a-regulated recycling
pathway could also be involved in the hypersecretion of aSYN
from HEK293T cells transfected with DN-VPS4A. To test this,
HEK293T cells doubly expressing aSYN and DN-VPS4A or SH-
SY5Y neuronal cells expressing DN-VPS4A were further co-
transfected with DN-Rab11a that lacks GTP-binding activity, then
whole cell lysates as well as CM were subjected to immunoblot
analysis (Fig. 7A and B, respectively). As shown in the blots, the
augmented secretion of over-expressed and endogenous aSYN
induced by VPS4 malfunction were effectively restored by the co-
expression of GDP-locked DN-Rab11a, whereas the total cellular
levels of aSYN remained unchanged.
Discussion
Until recently, aSYN has been considered to exert its
physiological as well as pathogenic effects intracellularly. However,
accumulating evidence suggests that both monomeric and
oligomeric aSYN can be secreted into the extracellular environ-
ment, thereby affecting the normal physiological state of
neighboring neuronal and glial cells [17]. In the case of prion
protein, cell-to-cell transmission by means of exosome shuttle,
caveolae-mediated endosomal pathway, and tunneling nanotubes
has been suggested [23,25,52,53]. Therefore, it is tempting to
speculate that similar mechanisms could be involved in the
transmission of other amyloidogenic proteins. Given that the prion
enrichment and infectivity were confirmed in the cell culture
media of infected cells as well as body fluids from suffering
animals, prion transfer could occur by a process other than
through direct cell contact [25,41,43]. In addition to prion protein,
several reports suggested that exosomes may serve as vehicles for
the transcellular spread of amyloidogenic proteins in neurodegen-
erative diseases including PD [17,54,55,56]. As reported previ-
ously [23,24,25], we found a striking condensation of prion in
exosomes in CM and human CSF, whereas such enrichment was
not observed with aSYN (Fig. 2A, 2B and 2C). The marked
discrepancy in terms of the exosomal localization implies that the
secretory mechanism of aSYN might be different from that of
prion protein. This idea is also supported by our findings showing
that, in contrast to prion protein, the suppression of MVB-
exosome biogenesis by DN VPS4A significantly increased the
extracellular aSYN in non-neuronal and neuronal cells (Fig.3A
and 4A). It is true that our results would seem to conflict with
previous reports demonstrating that aSYN is secreted from
Figure 3. Over-expression of DN VPS4 in HEK293T cells leads to increased extracellular a-synuclein and parallel decrease in
lysosome. A. aSYN-expressing HEK293T cells were co-transfected either with 3XFLAG-tagged wt-VPS4A or DN mutant (E228Q) VPS4A. Forty-eight
hours after transfection, HEK293T cells were fractionated into the cytosol (S3), endosome (P4), and lysosome (S4). Fractionated cell lysates as wella s
protein extracts from the culture medium (50 mg protein per lane) were subjected to Western immunoblot analysis using anti-Myc, anti-ubiquitin,
anti-FLAG/M2 Abs. Each fraction was verified by the presence of a specific marker protein: LAMP-1 (late endosome and lysosome), Rab5 (early
endosome), Rab11 (recycling endosome), Hsp90 (cytosol), and BSA (culture medium). As shown in the blot, marked increase of extracellular aSYN
monomer and multimers (white arrow) concomitant with slightly decreased lysosomal aSYN-immunopositive smear (open triangle) were observed by
over-expression of DN VPS4A. Note that endosomal proteins including aSYN seemed to be heavily ubiquitylated (hash). Asterisk indicates
endogenous myc band. B. Treatment with lysosomal inhibitor bafilomycin A1 (0–10 nM) for 24 hours induced the buildup of cellular aSYN oligomers
(asterisk) in parallel with the increase of extracellular aSYN monomer (closed triangle). C. Subcellular localization of Myc-aSYN (red) in HEK293T cells
expressing wt or DN VPS4A (magenta). LAMP-1 (green) was used as a marker for late endosome and lysosome. DN VPS4 distibuted as aberrant
cytoplasmic punctate structures, showing a marked contrast to wt-VPS4A with diffuse perinuclear distribution. Representative Western blots from
three separate experiments are shown. Scale bar: 10 mm.
doi:10.1371/journal.pone.0029460.g003
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pathological conditions [27,28]. However, it remains possible that
aSYN might be secreted through different secretory pathways
depending on the size of the aggregates or cellular condition.
Indeed, part of the newly synthesized aSYN was rapidly secreted
from MES cells via unconventional, endoplasmic reticulum/
Golgi-independent exocytosis [49]. Another study has demon-
strated that the internalized extracellular aSYN was resecreted out
of neurons via a process modulated by the recycling endosome
regulator Rab11a [50]. The functional importance of the recycling
pathway was also verified in the cellular trafficking of amyloid-b
precursor protein [57]. Our result showing that DN-Rab11a
restored the aberrant aSYN secretion triggered by impaired MVB
genesis also supports the functional relevance of the recycling
pathway in aSYN secretion. Supposedly, under the physiological
state, endosomal aSYN is destined for lysosomal degradation
(Fig. 8A) or introduced into the extracellular milieu through the
Rab11a-dependent recycling endosomal pathway (Fig. 8B) and, to
Figure 4. Expression of DN VPS4A increases wt as well as A53T mutant a-synuclein in SH-SY5Y neuronal cells. A. SH-SY5Y cells inducibly
expressing wt or A53T mutant aSYN were further co-transfected with 3XFLAG-tagged wt or DN E228Q mutant VPS4A plasmids. After 48 hours of aSYN
induction with doxycycline, whole cell and proteins from culture media (50 mg protein per lane) were subjected to immunoblot analysis using anti- synuclein-
1 and anti-FLAG/M2 antibody. Hsp90 and BSA were used as markers for cytosol and culture medium, respectively. Increased extracellular secretion of wta n d
A53T mutant aSYN were observed by DN VPS4A. Note that the extracellular secretion of monomeric wt-aSYN (black arrow) was higher than that of A53T
mutant aSYN (closed triangle) in mock-transfected cells as well as in DN-VPS4A engineered cells. Representative immunoblots from three independent
experiments are shown. B. Densitometric measurement of monomeric aSYN secreted into culture media. Values indicate the ratio of aSYN monomer to BSA.
S i g n i f i c a n ti n c r e a s eo fw ta sw e l la sA 5 3 TaSYN in culture media was observed by co-expression of wt and or DN VPS4A (*p,0.05, **p,0.005).
doi:10.1371/journal.pone.0029460.g004
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intracellular aSYN reaches a toxic level or the MVB sorting
pathway is dammed up for any reason, a torrent of endocytic
aSYN may flow out mainly through the recycling endosome
pathway. Perhaps the recycling pathway might serve as a ‘‘vent’’ to
discharge excess aSYN that would be potentially harmful to cells.
Another important finding observed in this study is that the
extracellular secretion of wt-aSYN was constitutively higher than
A53T mutant aSYN in mock-transfected cells as well as in DN-
VPS4A engineered cells. This finding is interesting when
considering the cytotoxic property of mutant aSYN, which might
be liable to be entrapped inside the cells and eventually lead to
cell-autonomous degeneration. It should be noted that we used cell
lines over-expressing aSYN in some experiments of this study.
Therefore, we cannot completely exclude the possibility that over-
expressed aSYN itself might somehow affect its subcellular
distribution since over-expression of aSYN hinders vesicle
trafficking and recycling as a result of interaction with prenylated
Rab acceptor protein 1 [58].
Since aSYN does not contain a predicted transmembrane
domain or known lipid anchor, there remains a fundamental
question on how it associates with endosomal vesicles. It is known
that the amino-terminal amphipathic a-helical domain of aSYN is
quite similar to the class A2 a-helix found in the lipid-binding
motif of several apolipoproteins [59]. In fact, aSYN binds artificial
liposomes containing phospholipid vesicles with acidic head
groups, lipid droplets, and lipid rafts [49]. It has been shown that
the portion of aSYN stably cofractionated with vesicles from brain
tissues and cultured neuronal cells was not only bound to the outer
membrane but certainly localized in the vesicle lumen [49].
Therefore, aSYN might be integrated into vesicles in at least two
different ways. Namely, some are loosely bound to the surface of
vesicles where the interaction is controlled in the balance of the
free cytosolic aSYN. The others are incorporated and sequestrated
into the lumen of vesicles. The mechanism by which cytosolic
aSYN moves into the endosomal vesicle is poorly understood;
however, apart from the vesicle permeabilization by protofibrillar
aSYN [60,61], intracellular aSYN exocytosed into the extracel-
lular space could be internalized and directly packaged into the
endosomal vesicles [15,49,62]. Intriguingly, it is known that the
aggregation of aSYN was faster and more robust in the vesicles
than in the cytosol [49,63]. We also observed a noticeable
Figure 5. VPS4 was found to be a component of Lewy body. Paraffin embedded sections including the substantia nigra and the temporal
lobes from four patients with PD with a mean age of 77.5 years and the controls with a mean age of 77.3 years were subjected to
immunohistochemical analysis using anti-human VPS4 Ab. Diaminobenzidine were used to visualize the staining and nuclei were counterstained with
hematoxylin. In all brain tissues from patients with PD, the core structures of Lewy bodies showed VPS4 immunoreactivity (Fig. 5). Only weak
background staining was observed in control brain sections (data not shown). The percentage of VPS4-immunoreactive Lewy bodies in the substantia
nigra (A and B) and the temporal lobes (C and D) of PD brains were 90% and 10%, respectively. Scale bar: 20 mm.
doi:10.1371/journal.pone.0029460.g005
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structures of Lewy bodies showed immnoreactivity with VPS4 Ab.
These findings are interesting when considering the biogenesis of
Lewy bodies, because the pale body, an early cytoplasmic change
before Lewy body maturation, often contains ubiquitinated
proteins as well as lysosomes and vacuolar structures [64,65]. It
is uncertain why intravesicular aSYN has a high propensity to
form aggregates. However, specific environments inside the vesicle
such as a high calcium concentration and low pH as well as the
molecularly crowded milieu might synergistically promote aSYN
fibrillization [66,67,68,69]. In addition, the extensive ubiquitina-
tion of endosomal aSYN found in this study may indicate a role
for ubiquitin in aSYN sorting along the endosomal pathway, since
multiple monoubiquitylation and Lys-63-linked polyubiquitylation
have been recognized as important sorting signals for cargo
proteins in the endosome membrane [33,70].
In summary, we found that impaired MVB-exosome biogenesis
by DN VPS4A strikingly increased extracellular aSYN, which was
correlated with the decreased lysosome-resident aSYN. The
inhibited recycling efficiency by DN-Rab11a can not only cause
a decrease of the extracellular aSYN oligomer but also restore the
hypersecretion of aSYN by DN-VPS4A. Furthermore, VPS4 was
found to be a component of the nigral as well as the cortical Lewy
bodies. Our results demonstrate how failure of the MVB sorting
machinery contributes to the extracellular secretion as well as
lysosomal targeting of aSYN and may thus be involved in the
propagation of Lewy pathology in PD. The importance of the
endosomal/lysosomal transport system in the pathogenesis of PD
is also highlighted by very recent findings that a mutation in VPS35
gene encoding a retromer complex involved in the retrograde
transport of proteins from the endosome to the trans-Golgi
network causes late-onset familial PD [71,72]. Furthermore, in a
manner similar to vaccination therapy, a reduction of the
extracellular aSYN brain burden by regulating the MVB sorting
could be a novel therapeutic strategy for PD and other
synucleinopathies. Although the concept of prion-like propagation
has been recognized as a common phenomenon in many
neurodegenerative diseases, it is likely that the molecular
mechanisms underlying the spreading of protein-misfolding may
differ depending on the biochemical nature of the protein
Figure 6. Part of the cellular a-synuclein was trafficked via a recycling endosome pathway for extracellular secretion. HEK293T cells
expressing Myc-aSYN were co-transfected with mock (EGFP), EGFP-wt-Rab11a, EGFP-CA-Rab11a, or EGFP-DN-Rab11a expression plasmids. At
48 hours following transfection, the cells were harvested and fractionated into cytosol, endosome, and lysosome. Fractionated samples as well as
total proteins from the culture media (50 mg per lane) were subjected to immunoblot analysis using anti-Myc, anti-EGFP Abs. A successful fraction
was verified by the presence of a specific marker proteins. As shown in the blot, secretion of aSYN oligomer in culture medium was partly reduced by
the over-expression of GDP-locked DN-Rab11a (asterisk), accompanied by the extensive retention of HMW aSYN species in the endosome (double
asterisk). Representative blots from three separate experiments are shown.
doi:10.1371/journal.pone.0029460.g006
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will be needed to gain insight into the cellular mechanisms of
disease progression and to identify molecular targets for thera-
peutic intervention in PD and other neurodegenerative diseases.
Materials and Methods
Plasmid Construction and Preparation
N-terminal Myc-tagged wild-type (wt) aSYN was subcloned into
the BglII and NotI sites of pCMV mammalian expression vector
(Invitrogen, Carlsbad, CA). For inducible expression, human wt
and A53T mutant aSYN cDNAs were introduced into pcDNA4/
TO doxycycline (Dox)-inducible expression vector (Invitrogen)
using the restriction enzymes KpnI and NotI. The plasmid
pcDNA6/TR encoding tetracycline repressor protein was pur-
chased as a part of the T-REx tetracycline-regulated mammalian
expression system (Invitrogen). Triple FLAG (3xFLAG)-tagged
human wt- and DN E228Q VPS4A were subcloned into the EcoRI
and BamHI sites of pCMV vector. The pEGFP-C1 plasmids
encoding EGFP-tagged human wt-Rab5a, wt-Rab7, wt-Rab11a,
CA-Q70L-Rab11a, DN-S25N-Rab11a were kindly provided by
Dr. Mitsunori Fukuda (Laboratory of Membrane Trafficking
Mechanisms, Department of Developmental Biology and Neuro-
sciences, Tohoku University Biological Institute, Sendai, Japan).
Plasmid DNAs were isolated and purified using the GenoPure
Plasmid Maxi Kit (Roche, Indianapolis, IN). The fidelity and
orientation of the expression constructs were confirmed by
restriction enzyme digestion and/or nucleotide sequence analyses.
Cell Culture and Transfection
HEK293T human embryonic kidney cells (kindly gifted by Dr.
Taeko Miyagi, Institute of Molecular Biomembrane and Glyco-
biology, Tohoku Pharmaceutical University, Sendai, Japan) and
SH-SY5Y human dopaminergic neuroblastoma cells (CRL-2266;
American Type Culture Collection, Manassas, VA) were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM; Invitro-
gen/GIBCO) containing 4.5g/l glucose, 2mM L-glutamine
(Invitrogen) supplemented with 10% fetal bovine serum (FBS;
Thermo Scientific/HyClone, Rockford, IL) at 37
oC under
humidified 5% CO2/air. The SH-SY5Y cell lines in which wt
or A53T mutant aSYN can be induced were established using the
T-REx expression system which consists of two key expression
vectors, pcDNA4/TO and pcDNA6/TR [73,74]. Stably trans-
fected Dox-inducible SH-SY5Y cells were maintained in DMEM
containing 4.5g/l glucose, 2mM L-glutamine supplemented with
10% FBS under selective pressure by 5 mg/ml Blasticidin and
300 mg/ml Zeocin (both from InvivoGen, San Diego, CA).
HEK293T cells seeded 24 hours prior to transfection were
transiently transfected using FuGENE 6 transfection reagent
(Roche) at FuGENE 6 ( ml)/DNA ( mg) ratio of 3:1. SH-SY5Y cells
were nucleofected using the Nucleofector I device (LONZA AG,
Cologne, Germany) with program A-023. Cells were harvested
48 hours post transfection unless otherwise stated. To evaluate
aSYN decay in the presence of lysosomal inhibitor, cells were
treated with bafilomycin A1 (0–10 nM dissolved in DMSO;
purchased from Sigma) for 24 hours.
Immunofluorescence Confocal Microscopy and
Immunohistochemistry
Cells seeded onto UV-sterilized coverslips coated with self-made
rat-tail collagen were fixed in 4% (w/v) paraformaldehyde in PBS
for 10 min, permeabilized with 0.5% Triton X-100 in PBS for
5min, and blocked with 3% normal goat serum (Wako Pure
Chemical Industries, Osaka, Japan) in PBS for 30min. Primary
antibodies (rat monoclonal antibody (mAb) anti-DYKDDDDK
(FLAG peptide)-tag (1:500; Agilent Technologies, Foster City CA),
mouse mAb anti-cMyc (clone 9E10, 1:1000; DSHB, Iowa City,
IA), rabbit pAb anti-aSYN (1:1000, CST, Danvers, MA) and
mouse mAb anti-LAMP-1 (clone H4A3, 1:1000; DSHB)) were
applied for 2 hours followed by anti-mouse IgG Alexa 488
conjugates, anti-rabbit IgG Alexa 568 conjugates, or anti-rat IgG
Alexa 647 conjugates (1:2000; Invitrogen/Molecular Probes) for 1
hour. Nuclei were counterstained with TO-PRO3 iodide and
pseudo-colored as blue (Invitrogen/Molecular Probes). After
immunostaining, coverslips were placed upside down on a drop
of PermaFluor antifade mounting medium (Thermo Scientific).
Fluorescent images were analyzed with a FV300 confocal laser
scanning microscope system equipped with HeNe-Green
(543 nm), HeNe-Red (633 nm) and Ar (488 nm) laser units
(Olympus Corporation, Tokyo, Japan). In the multiple labeling
Figure 7. Increased secretion of a-synuclein by DN-VPS4A is
restored by DN-Rab11a. GDP-locked DN-Rab11a strikingly restored
the hypersecretion of aSYN triggered by the impaired MVB sorting
pathway (closed triangle). HEK293T cells co-expressing Myc-aSYN and
3XFLAG-DN-VPS4A (A) and SH-SY5Y neuronal cells expressing 3XFLAG-
DN-VPS4A (B) were further transfected with EGFP-DN-Rab11a. Forty
eight hours post transfection, the cells were harvested and solubilized
in RIPA buffer. Whole cell lysates as well as total proteins from culture
media (50 mg per lane) were then subjected to immunoblot analysis
using anti-Myc, anti-synuclein-1, anti-FLAG, and anti-EGFP Abs. Hsp90
and BSA were used as markers for the cytosol and culture medium,
respectively. Asterisk indicates unspecific band. Representative blots
from three independent experiments are presented.
doi:10.1371/journal.pone.0029460.g007
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each wavelength separately and then merged using Fluoview
image analyzing software (version 4.3, Olympus). For immuno-
histochemistry, 4-mm-thick sections of formalin fixed paraffin
embedded samples including the substantia nigra and the
temporal lobes from patients with PD with a mean age of 77.5
years (n=4, range 67 to 84 years) and the controls with a mean
age of 77.3 y (n=4, range 67 to 87 years) were subjected to
immunohistochemical investigations using the avidin-biotin-per-
oxidase complex (ABC) method with a Vectastain ABC kit (Vector
Laboratories, Burlingame, CA). Polyclonal Ab against human
VPS4 (SAB4200025, 1:100; Sigma) was used as primary Ab.
Diaminobenzidine was used as the chromogen. The sections were
counterstained with hematoxylin. No pretreatment of sample
before Ab incubation was required.
Subcellular Fractionation by Sequential Centrifugation
For the subcellular fractionation of cultured cells, we adopted an
established protocol with slight modifications [75]. All steps of the
fractionation scheme were carried out at 0–4uC with ice-cold
reagents. Cells (1610
7) were resuspended with 2 ml ice-cold
Figure 8. Schematic presentation of endosomal pathways and the functional relevance of MVB sorting machinery and Rab11a-
mediated recycling pathway in the secretion as well as lysosomal targeting of a-synuclein. Membrane-associated cargo proteins
including aSYN are translocated to early endosomes, which also receive cargoes from the trans-Golgi network. Some cargoes are recycled back to the
plasma membrane. Others are sequestered in intraluminal vesicles of MVB. Individual ESCRT proteins and VPS4 contribute to MVB formation through
the induction of invagination and final scission of the endosomal membrane. MVB directs either for lysosomal degradation or for secretion as
exosomes by exocytic fusion with the plasma membrane. Under the physiolosical condition, aSYN in the early endosome may be transferred to MVB
then targeted for lysosomal degradation (A). Alternatively, part of the endosomal aSYN may be cast into the extracellular milieu through the Rab11a-
dependent recycling endosome (B) and, to a lesser degree, MVB-exosome pathway (C). If the intracellular aSYN reaches a toxic level or the MVB
sorting is dammed up, excessive amounts of endocytic aSYN will flow out mainly through the recycling endosome pathway.
doi:10.1371/journal.pone.0029460.g008
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sucrose) and homogenized using 20 strokes in a 2-ml Dounce
tissue grinder with a tight pestle (GPE, Bedfordshire, England).
The cell homogenate was initially cleared by three successive
centrifugation steps (5006g for 2 min, 1,0006g for 2 min, 2,0006g
for 2 min) to remove debris and undestroyed cells. The
supernatant was transferred to a new tube and centrifuged at
4,0006g for 2 min to pellet the plasma membrane and nuclei. The
supernatant was ultracentrifuged at 100,0006g (P50S2 swing
rotor, Hitachi Koki Co., Ltd., Tokyo, Japan) for 2 min to pellet
the mitochondria, endosomes, and lysosomes (fraction EL).
Lysosomes were isolated from the fraction EL by 10-min osmotic
lysis using five times the pellet volume of distilled water. After
another centrifugation step with 100,0006g for 2min, lysosomes
remained in the supernatant, while mitochondria and endosomes
were in the pellet.
TCA/acetone Protein Extraction from Culture Medium
and CSF
Total protein in CM and CSF was extracted by trichloroacetic
acid (TCA)/acetone precipitation protocol. Briefly, freshly col-
lected samples were cleared by three successive centrifugation
steps (8006g for 5 min, 2,0006g for 10 min, and 10,0006g for
20 min at 4uC) to pellet the debris and intact cells. The
supernatant was transferred to a new tube and added with an
equal volume of ice-cold 20% TCA/acetone, followed by
incubation at 220uC for 3 hours. After adding 3 additional
volumes of ice-cold acetone, proteins were allowed to precipitate
overnight at 220uC. The protein was pelleted by centrifugation at
5,0006g for 60min, dissolved in 8M urea/5% SDS with
sonication, and subjected to Western immunoblot analyses.
Exosome Isolation from Culture Medium and CSF
To isolate exosomes, CM or pooled CSF was collected and
subjected to a multi-step differential centrifugation process. In
brief, freshly collected samples were subjected to three successive
centrifugations at 8006g for 5 min, 2,0006g for 10 min, and
15,0006g for 20 min at 4uC to remove debris and intact cells.
After filtration through a 0.22 mm Millipore syringe filter,
exosomes were pelleted by ultracentrifugation at 100,0006g
(P40ST swing rotor, Hitachi Koki, Co., Ltd.) for 1 hour at 4uC.
In some experiments, the exosome-containing pellet was resus-
pended in ice-cold PBS and further purified by continuous linear
sucrose-density gradient centrifugation (2.0–0.25M sucrose,
20 mM HEPES, pH 7.2) according to the method described
previously. The exosomal proteins Alix and flotillin-1 were used as
markers for the exosome-containing fraction [27].
SDS-Polyacrylamide Gel Electrophoresis and Western
Immunoblot Analysis
After preparing the cell lysates using radio-immunoprecipitation
assay (RIPA) buffer (1% NP-40, 0.5% deoxycholate, 0.1% sodium
dodecyl sulfate (SDS), 1mM EDTA, 10mM sodium pyrophos-
phate, 50mM sodium fluoride, 1mM sodium orthovanadate,
150mM sodium chloride, 50mM Tris-HCl (pH 8.0) plus 1x
Cømplete protease inhibitor cocktail; Roche), the protein
concentration was determined using a bicinchoninic acid (BCA)
protein assay kit (BioRad, Hercules, CA). Lysates containing 50 mg
total protein were boiled in Laemmli loading buffer and then
electrophoresed on denaturing 12.5% SDS-polyacrylamide gels
using the Mini-PROTEAN 3 cell system (BioRad). Electroblotting
onto polyvinylidene fluoride membrane (Immobilon-P; Millipore,
Bedford, MA) was performed at 100V for 2 hours. After a
blocking step with Tris-Buffer Saline (TBS: 50 mM Tris-HCl,
pH 7.5, 150 mM NaCl) with 0.05% Tween 20 (TBST) supple-
mented with 5% nonfat dry milk, membranes were incubated with
anti-cMyc mouse mAb (clone 9E10, 1:1000; DSHB), M2 anti-
FLAG/M2 (1:1000; Sigma) mouse mAb, anti-GFP mouse mAb
(1:4000; MBL, Nagoya, Japan) anti-synuclein-1 mouse mAb
(1:1000; BD Bioscience, San Jose, CA), anti-Alix mouse mAb
(clone 3A9, 1:1000; CST), anti-flotillin-1 mouse mAb (1:500; BD
Transduction laboratories, Franklin Lakes, NJ), anti-Hsp90 mouse
mAb (1:4000; Stressgen, Victoria, BC, Canada), anti-BSA rabbit
polyclonal antibody (pAb) (clone B-140, 1:4000; Santa Cruz
Biotechnology, Santa Cruz, CA), anti-prion protein mouse mAb
(1:1000; Sigma), anti-ubiquitin Ab (clone P4D1, 1:1000; Santa
Cruz), anti-LAMP-1 mouse mAb (clone H4A3, 1:1000, DSHB),
anti-Rab5 rabbit pAb (1:4000, Santa Cruz), and anti-Rab11 rabbit
pAb (1:1000; CST, Danvers, MA). Primary antibodies were
followed by horseradish peroxidase-conjugated secondary Ab
(1:10000; Jackson ImmunoResearch Laboratories, West Grove,
PA). Bands were visualized with Immobilon Western Chemilumi-
nescent HRP Substrate (Millipore) and images were captured by
the LAS-3000mini lumino image analyzer (Fujifilm, Tokyo,
Japan). Quantification of the band intensity was performed using
the Image J version 1.44 software for Mac (developed at the
National Institutes of Health, Bethesda, MD) [76]. All experiments
were performed at least three times with identical results.
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